欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4286/005
药品名称Lenalidomide Grindeks 15 mg
活性成分
    • lenalidomide 15.0 mg
剂型Capsule, hard
上市许可持有人AS Grindeks Krustpils Iela 53, LV-1057,Riga,Latvia
参考成员国 - 产品名称Netherlands (NL)
Lenalidomide Grindeks 15 mg harde capsules
互认成员国 - 产品名称
    • Germany (DE)
      Lenalidomide Grindeks 15 mg Hartkapseln
    • Sweden (SE)
    • Greece (GR)
    • Finland (FI)
    • Ireland (IE)
    • Iceland (IS)
    • Portugal (PT)
    • Denmark (DK)
      Lenalidomid ”Grindeks”
    • Norway (NO)
    • Cyprus (CY)
      Lenalidomide Grindeks 15 mg capsule, hard
    • Croatia (HR)
      Lenalidomid Grindeks 15 mg tvrde kapsule
    • Slovenia (SI)
    • France (FR)
    • Slovakia (SK)
      Lenalidomid Grindeks 15 mg tvrdé kapsuly
    • Romania (RO)
      Lenalidomide Grindeks 15 mg capsule, tari
    • Czechia (CZ)
      Lenalidomide Grindeks
    • Bulgaria (BG)
      Lenalidomide Grindex
    • Hungary (HU)
      LENALIDOMIDE GRINDEKS 15 mg kemény kapszula
    • Estonia (EE)
      LENALIDOMIDE GRINDEKS
    • Lithuania (LT)
      Lenalidomide Grindeks 15 mg kietosios kapsulės
    • Latvia (LV)
      Lenalidomide Grindeks 15 mg cietās kapsulas
    • Poland (PL)
    • Malta (MT)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Spain (ES)
    • Austria (AT)
    • Italy (IT)
许可日期2019/08/21
最近更新日期2025/09/28
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase